[Helicobacter pylori, nonsteroidal anti-inflammatory agents and gastroduodenal changes].
The author discusses the possible interactions between non-steroidal anti-inflammatory drugs (NSAIDs) and Helicobacter pylori (Hp) which may play an important role in the unleashing of gastroduodenal lesions. To our knowledge, AINEs have no influence on the prevalence of infection by Hp and the latter does not seem to influence the development and intensity of the lesions caused by NSAIDs.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D004381:Duodenal Ulcer / Q000453:epidemiology / Q000209:etiology*; D004386:Duodenum / Q000187:drug effects*; D016481:Helicobacter Infections / Q000453:epidemiology / Q000209:etiology*; D016480:Helicobacter pylori / Q000472:pathogenicity*; D006801:Humans; D015995:Prevalence; D012307:Risk Factors; D013270:Stomach / Q000187:drug effects*; D013276:Stomach Ulcer / Q000453:epidemiology / Q000209:etiology*
D000894:Anti-Inflammatory Agents, Non-Steroidal
Helicobacter pylori, anti-inflamatórios não esteroides e alterações gastro-duodenais.